NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 37 filers reported holding NEUROCRINE BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,195,521 | +2.6% | 1,546,000 | -4.2% | 0.02% | 0.0% |
| Q2 2022 | $2,139,249 | +99.8% | 1,614,000 | +98.3% | 0.02% | +157.1% |
| Q1 2022 | $1,070,922 | +0.9% | 814,000 | -3.6% | 0.01% | +16.7% |
| Q4 2021 | $1,061,002 | -53.7% | 844,000 | -51.2% | 0.01% | -57.1% |
| Q2 2021 | $2,292,849 | -57.0% | 1,729,000 | -55.2% | 0.01% | -76.3% |
| Q3 2020 | $5,337,000 | -39.5% | 3,859,000 | -27.1% | 0.06% | -43.3% |
| Q2 2020 | $8,822,000 | +51.8% | 5,293,000 | +16.7% | 0.10% | +62.5% |
| Q1 2020 | $5,811,000 | -8.9% | 4,536,000 | +9.1% | 0.06% | +30.6% |
| Q4 2019 | $6,376,000 | +5915.1% | 4,158,000 | +5300.0% | 0.05% | +4800.0% |
| Q3 2019 | $106,000 | -26.9% | 77,000 | -30.0% | 0.00% | 0.0% |
| Q2 2019 | $145,000 | -12.7% | 110,000 | -10.6% | 0.00% | 0.0% |
| Q1 2019 | $166,000 | -92.8% | 123,000 | -93.6% | 0.00% | -94.7% |
| Q4 2018 | $2,297,000 | -9.2% | 1,924,000 | 0.0% | 0.02% | +35.7% |
| Q1 2018 | $2,530,000 | – | 1,924,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CSS LLC/IL | 15,659,000 | $23,207,687 | 1.52% |
| SONA ASSET MANAGEMENT (US) LLC | 17,500,000 | $26,317,952 | 1.09% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 26,765,000 | $40,113,099 | 0.86% |
| Warberg Asset Management LLC | 1,271,000 | $1,885,846 | 0.38% |
| SSI INVESTMENT MANAGEMENT LLC | 2,296,000 | $3,406,116 | 0.28% |
| Paloma Partners Management Co | 3,125,000 | $4,694,590 | 0.16% |
| FRANKLIN RESOURCES INC | 54,750,000 | $81,769,125 | 0.04% |
| Rock Springs Capital Management LP | 1,000,000 | $1,497,950 | 0.04% |
| LORD, ABBETT & CO. LLC | 4,666,000 | $6,922 | 0.03% |
| D. E. Shaw & Co., Inc. | 14,351,000 | $21,373,197 | 0.02% |